CK Hutchison Holdings Ltd., of London, said it intends to sell approximately 1.3% of the total outstanding share capital in Hutchison China Meditech Ltd., of Hong Kong, through an underwritten public offering, which would reduce its stake in the company from 51.1% to 49.9%.